Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Holding(s) in Company

12th May 2009 15:05

RNS Number : 1186S
Neuropharm Group PLC
12 May 2009
 



For immediate release

12 May 2009

Neuropharm Group plc

("Neuropharm" or the "Company")

TR-1: Notification of Major Interests in Shares

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

Neuropharm Group plc

2. Reason for the notification 

An acquisition or disposal of voting rights

Yes

3. Full name of person(s) subject to the notification obligation:

Schroders plc

4. Full name of shareholder(s) (if different from 3.):

5. Date of the transaction (and date on which the threshold is crossed or reached if different):

11 May 2009

6. Date on which issuer notified:

12 May 2009

7. Threshold(s) that is/are crossed or reached:

10%

8. Notified details:

A: Voting rights attached to shares

Class/type of shares

if possible using the ISIN CODE

Situation previous to the Triggering transaction

Resulting situation after the triggering transaction

Number of Shares

Number of Voting Rights

Number of shares

Number of voting rights

% of voting rights

Direct

Direct

Indirect

Direct

Indirect

Ord 10p Shares

ISIN

GB00B1NPJJ01

3,346,458

3,346,458

3,146,458

N/A

3,146,458

N/A

9.98%

  

B: Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument 

Expiration date

Exercise/ Conversion Period/ Date

Number of voting rights that may be acquired if the instrument is exercised/ converted. 

% of voting rights

N/A

Total (A+B)

Number of voting rights

% of voting rights

3,146,458

9.98%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:

Schroder Investment Management Limited 3,146,458 9.98%

Proxy Voting:

10. Name of the proxy holder:

N/A

11. Number of voting rights proxy holder will cease to hold:

N/A

12. Date on which proxy holder will cease to hold voting rights:

N/A

13. Additional information:

The shares referred to in section 9 are held in portfolios managed by those firms on a discretionary basis for clients under investment management agreements.

14. Contact name:

Andrea Rowe

15. Contact telephone number:

00 44 207 658 6000

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUURSRKORVAAR

Related Shares:

Schroders
FTSE 100 Latest
Value8,942.23
Change75.21